Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Guanya Guo
Observed names:
G. Guo,
G.-Y. Guo,
Guan-ya Guo,
Guo Guanya
Institutions:
National Clinical Research Center for Digestive Diseases,
Xijing Hospital,
Air Force Medical University
Observed institutions:
National Clinical Research Center for Digestive Diseases,
Xijing Hospital,
State Key Laboratory of Cancer Biology,
Air Force Medical University
ORCID:
0000-0001-5115-1632
Observed ORCID:
0000-0001-5115-1632
OpenAlex ID:
A5048053884
Serum vitamin D level is associated with disease severity and response to ursodeoxycholic acid in primary biliary cirrhosis
2015
·
G.-Y. Guo
, Y.-Q. Shi
, et al.
·
Alimentary Pharmacology & Therapeutics
·
66
Effectiveness of Fenofibrate in Treatment-Naive Patients With Primary Biliary Cholangitis: A Randomized Clinical Trial
2023
·
Yansheng Liu
, Guanya Guo
, et al.
·
The American Journal of Gastroenterology
·
58
Induction of hepatocyte‐like cells from human umbilical cord‐derived mesenchymal stem cells by defined microRNAs
2016
·
Xia Zhou
, Lina Cui
, et al.
·
Journal of Cellular and Molecular Medicine
·
53
PDF
Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion
2022
·
Chunmei Yang
, Guanya Guo
, et al.
·
Hepatology International
·
35
PDF
Efficacy and safety of fenofibrate addition therapy in patients with cirrhotic primary biliary cholangitis with incomplete response to ursodeoxycholic acid
2022
·
Dawei Ding
, Guanya Guo
, et al.
·
Hepatology Communications
·
26
PDF
Prognostic significance of liver stiffness in patients with primary biliary cholangitis: validation of Baveno VII criteria
2023
·
Dawei Ding
, Guanya Guo
, et al.
·
Hepatology International
·
22
PDF
Characterisation of Lamp2-deficient rats for potential new animal model of Danon disease
2018
·
Shuoyi Ma
, Miao Zhang
, et al.
·
Scientific Reports
·
21
PDF
Host FSTL1 defines the impact of stem cell therapy on liver fibrosis by potentiating the early recruitment of inflammatory macrophages
2025
·
Xiaohong Zheng
, Siyuan Tian
, et al.
·
Signal Transduction and Targeted Therapy
·
20
A Critical Evaluation of Liver Pathology in Humans with Danon Disease and Experimental Correlates in a Rat Model of LAMP-2 Deficiency
2017
·
Lu Wang
, Jingbo Wang
, et al.
·
Clinical Reviews in Allergy & Immunology
·
20
Immunoglobulin M: A Neglected Serum Biomarker in Treatment‐Naive Primary Biliary Cholangitis With Normal Alkaline Phosphatase
2022
·
Dawei Ding
, Guoyun Xuan
, et al.
·
Hepatology Communications
·
19
PDF
The prognostic value of anti-gp210 and anti-centromere antibodies in patients with primary biliary cholangitis: Enhancing the prognostic utility on the GLOBE scoring system
2025
·
Dawei Ding
, Gui Jia
, et al.
·
Digestive and Liver Disease
·
18
Long-term Outcomes of Autologous Peripheral Blood Stem Cell Transplantation in Patients With Cirrhosis
2018
·
Changcun Guo
, Guanya Guo
, et al.
·
Clinical Gastroenterology and Hepatology
·
18
Integrative bioinformatics analysis and experimental validation of key biomarkers for risk stratification in primary biliary cholangitis
2023
·
Siyuan Tian
, Yinan Hu
, et al.
·
Arthritis Research & Therapy
·
17
PDF
Psoas Muscle Index Can Be Used to Predict Long-Term Mortality in Young Male Patients With Acute-on-Chronic Liver Failure
2022
·
Manman Xu
, Tongzeng Li
, et al.
·
Frontiers in Nutrition
·
17
PDF
Causal associations between gut microbiota and Cholestatic liver diseases: a Mendelian randomization study
2024
·
Jiaqi Yang
, Gang Ma
, et al.
·
Frontiers in Medicine
·
15
Efficacy and safety of fenofibrate add-on therapy in patients with primary biliary cholangitis refractory to ursodeoxycholic acid: A retrospective study and updated meta-analysis
2022
·
Xuan Guoyun
, Ding Dawei
, et al.
·
Frontiers in Pharmacology
·
14
Prevalence and effect on prognosis of sarcopenia in patients with primary biliary cholangitis
2024
·
Jiaqi Yang
, Shuangshuang Jiang
, et al.
·
Frontiers in Medicine
·
13
Bioinformatics Analysis Combined With Experiments Predicts PUDP as a Potential Prognostic Biomarker for Hepatocellular Carcinoma Through Its Interaction With Tumor Microenvironment
2022
·
Jiahao Yu
, Weirui Zhang
, et al.
·
Frontiers in Oncology
·
12
Engineered Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Mitigate Liver Fibrosis by Delivering USP10 to Reprogram Macrophage Phenotype
2025
·
Siyuan Tian
, Xia Zhou
, et al.
·
Biomaterials Research
·
10
Role of the FOXM1/CMA/ER stress axis in regulating the progression of nonalcoholic steatohepatitis
2025
·
Shuoyi Ma
, Erzhuo Xia
, et al.
·
Clinical and Translational Medicine
·
9
PDF
Definition and validation of recompensation in patients with primary biliary cholangitis-related decompensated cirrhosis treated with ursodeoxycholic acid: Based on the BAVENO VII criteria
2025
·
Dawei Ding
, Lina Cui
, et al.
·
Journal of Translational Internal Medicine
·
8
PDF
Fenofibrate normalizes alkaline phosphatase and improves long-term outcomes in patients with advanced primary biliary cholangitis refractory to ursodeoxycholic acid
2023
·
Dawei Ding
, Pengwei Ren
, et al.
·
Gastroenterología y Hepatología
·
8
A decline of LAMP- 2 predicts ursodeoxycholic acid response in primary biliary cirrhosis
2015
·
Lu Wang
, Guan-ya Guo
, et al.
·
Scientific Reports
·
8
PDF
Low-risk individuals with primary biliary cholangitis and significant liver stiffness: prognosis and treatment
2024
·
Dawei Ding
, Yinan Hu
, et al.
·
Hepatology International
·
7
PDF
Development and validation of a prognostic nomogram for early hepatocellular carcinoma treated with microwave ablation
2025
·
Jing Zhang
, Guanya Guo
, et al.
·
Frontiers in Oncology
·
6
Show more works
View as search
Works count:
46
Citation count:
554
H-index:
15
I10-index:
19
Year
Topic
Type